MPP Celebrates First UMIC Dolutegravir Shipments
Two Countries Supplied With HIV Treatment Just Three Months After Licenses Agreed
The Medicines Patent Pool has announced that the first shipments of dolutegravir under a fresh agreement covering upper-middle-income countries have reached Azerbaijan and Belarus.
You may also be interested in...
Viatris’ Mylan and Hetero Drugs have agreed to partner with the Medicines Patent Pool to supply dolutegravir in Azerbaijan, Belarus, Kazakhstan and Malaysia.
The Medicines Patent Pool is giving interested parties until 18 December to submit license applications for the HIV treatment dolutegravir in four middle-income countries, following announcement of the agreement last month.
Alvotech and Stada are on the verge of gaining the world’s second ever approval for a higher-strength Humira biosimilar, after the EMA’s CHMP endorsed the firms’ adalimumab under the names Hukyndra and Libmyris at its September meeting.